BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3806162)

  • 1. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
    J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
    Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
    Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Preisler HD; Epstein J; Barcos M; Priore R; Raza A; Browman GP; Vogler R; Winton E; Grunwald H; Rai K
    Br J Haematol; 1984 Sep; 58(1):19-32. PubMed ID: 6466567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.
    Preisler HD; Raza A; Larson R; Browman G; Goldberg J; Grunwald H; Vogler R; Bennett J; Gottlieb A; D'Arrigo P
    Cancer Chemother Pharmacol; 1986; 18(3):257-60. PubMed ID: 3802381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.
    Preisler HD; Azarnia N; Raza A; Grunwald H; Vogler R; Browman G; Goldberg J; Chervenick P; Miller K; Brennan J
    Br J Haematol; 1984 Mar; 56(3):399-407. PubMed ID: 6582925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.
    Goldberg J; Grunwald H; Vogler WR; Winton E; Browman G; Walker I; Benger A; Miller KB; Rai K; Gottlieb AJ
    Am J Hematol; 1985 Jun; 19(2):167-76. PubMed ID: 3890525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside--the Taiwan experience.
    Chen YC; Lin SF; Yao M; Chen TY; Tsao CJ; Chen TP
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):30-4. PubMed ID: 8916314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cytosine arabinoside for acute nonlymphocytic leukemia.
    Cantin G; Brennan JK
    Am J Hematol; 1984 Jan; 16(1):59-66. PubMed ID: 6695910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside.
    Balaban EP; Cox JV; Schneider NR; Harth CA; Haley BB; Sheehan R; Frenkel EP
    Am J Hematol; 1988 Oct; 29(2):79-84. PubMed ID: 3189306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.
    Preisler HD; Priore R; Azarnia N; Barcos M; Raza A; Rakowski I; Vogler R; Winton EL; Browman G; Goldberg J
    Br J Haematol; 1986 Aug; 63(4):625-36. PubMed ID: 3460626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
    Moriyama Y; Urushiyama M; Ohnishi M; Koyama S; Hirosawa H; Hanano M; Fuse I; Takai K; Nagayama R; Fujiwara M; Kishi K; Takahashi M; Koike T; Sakai C; Kashimura M; Miura R; Aoyagi A; Sanada M; Hattori A; Shibata A; Shinada S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1549-54. PubMed ID: 6892201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia.
    Lewis JP; Linman JW; Marshall GJ; Pajak TF; Bateman JR
    Cancer; 1977 Apr; 39(4):1387-96. PubMed ID: 322835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.